Package 0245-1075-30

{"route": ["ORAL"], "spl_id": "374eeb55-b017-48fd-e063-6294a90a6ad7", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0302451072309"], "unii": ["0H73WJJ391"], "rxcui": ["1494766", "1494769", "1494771", "1494775", "1494778", "1494781", "1812419", "1812421", "1812425", "1812427"], "spl_set_id": ["46f54677-3a22-4c38-9b92-923020164e15"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Upsher-Smith Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (0245-1075-30)  / 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE", "package_ndc": "0245-1075-30", "marketing_start_date": "20140411"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0245-1075-90)  / 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE", "package_ndc": "0245-1075-90", "marketing_start_date": "20140411"}], "brand_name": "QUDEXY XR", "product_id": "0245-1075_374eeb55-b017-48fd-e063-6294a90a6ad7", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0245-1075", "generic_name": "Topiramate", "labeler_name": "Upsher-Smith Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "QUDEXY", "brand_name_suffix": "XR", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "150 mg/1"}], "application_number": "NDA205122", "marketing_category": "NDA", "marketing_start_date": "20140411", "listing_expiration_date": "20261231"}